Previous Close | 151.74 |
Open | 149.34 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 149.34 - 151.38 |
52 Week Range | 118.90 - 168.00 |
Volume | |
Avg. Volume | 3 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Insightful Analysis of AbbVie's Strengths, Weaknesses, Opportunities, and Threats
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.